Bir essitalopram intoksikasyonu ve siproheptadin
Abstract
Keywords
Supporting Institution
Project Number
Thanks
References
- Referans 1. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol. 2000;14:3-20.
- Referans 2. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112-20.
- Referans 3. Haberzettl R, Fink H, Bert B. Role of 5-HT(1A) and 5-HT(2A) receptors for the murine model of the serotonin syndrome. J Pharmacol Toxicol Methods 2014;70:129-33.
- Referans 4. Öztürk N, Kara Ö, Sözeri-Varma G, Değirmenci E. Düşük Doz Essitalopram ile Serotonin Sendromu: Journal of Mood Disorders Volume: 3, Number: 1, 2013 - www.jmood.org
- Referans 5. Hernandez M, Wals M, Ganti L. Serotonin Syndrome in the Emergency Department: Cureus. 2019;11(12):e630.
- Referans 6. Jones D, Story DA. Serotonin syndrome and the anaesthetist. Anaesth Intensive Care 2005;33:181-7.
- Referans 7. Arık AC. Serotonin Sendromu. Duygudurum Bozuklukları Dizisi 2003;1:346-351.
- Referans 8. Frye JR, Poggemiller AM, mcgonagill PW, Pape KO, Galet C, Liu YM. Use of Cyproheptadine for the Treatment of Serotonin Syndrome. Journal of Clinical Psychopharmacology, 2020;40(1):95–9.
Details
Primary Language
Turkish
Subjects
Surgery
Journal Section
Case Report
Authors
Canan Tiryaki
This is me
0000-0001-8190-9432
Türkiye
Zeki Korhan
This is me
0000-0001-8956-9356
Türkiye
Publication Date
December 31, 2020
Submission Date
February 6, 2020
Acceptance Date
July 4, 2020
Published in Issue
Year 2020 Volume: 3 Number: 3